Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Catalyst Pharmaceuticals (CPRX) Leases (2019 - 2025)

Historic Leases for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Q3 2025 value amounting to $2.0 million.

  • Catalyst Pharmaceuticals' Leases fell 1264.67% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 1264.67%. This contributed to the annual value of $2.2 million for FY2024, which is 1108.45% down from last year.
  • As of Q3 2025, Catalyst Pharmaceuticals' Leases stood at $2.0 million, which was down 1264.67% from $2.1 million recorded in Q2 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Leases peaked at $3.3 million during Q1 2021, and registered a low of $2.0 million during Q3 2025.
  • Moreover, its 5-year median value for Leases was $2.6 million (2023), whereas its average is $2.6 million.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Leases soared by 2532122.13% in 2021 and then plummeted by 1264.67% in 2025.
  • Quarter analysis of 5 years shows Catalyst Pharmaceuticals' Leases stood at $3.0 million in 2021, then fell by 8.19% to $2.8 million in 2022, then dropped by 9.46% to $2.5 million in 2023, then fell by 11.08% to $2.2 million in 2024, then decreased by 9.87% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.1 million for Q2 2025, and $2.2 million during Q1 2025.